COVID-19 Made Moderna Famous: Cancer Could Define Its Future
Moderna's Phase 3 cancer vaccine breakthrough could mark a turning point as the biotech company looks to move beyond its COVID-era identity.
Moderna is testing a new vaccine to fight cancer, which could become a big part of what the company does besides COVID vaccines. When a company tries something totally new like this, watch if it actually works—that shows whether they can succeed at more than just one thing.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.